The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): 20m
Expected first date of trading: 10/07/2014
Market: AIM
Location of address at which admission document will be available: The admission document, containing full details about Abzena plc and the admission of ordinary shares, will be available from the offices of Pinsent Masons, 30 Crown Place. Earl Street. London EC2A 4ES. On the date of admission the admission document will be available from the company website being http://www.abzena.com/
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): Cenkos Securities plc
Nominated Broker (AIM Companies): Cenkos Securities plc

Company details
Name Role
Kenneth Thomas Cunningham Chairman
William John Edward Burt Chief Executive Officer
Julian Matthew Smith Chief Financial Officer
Anthony David Brampton Non-Executive Director
Nigel Aaron Pitchford Non-Executive Director
Anker Lundemose Non-Executive Director
Peter William Grant. Non-Executive Director

Facts and Figures
Fiscal year end: 31 March
Incorporated in: UK
Website URL: http://www.abzena.com/
space
Description of business:
Abzena is a revenue-generating provider of services and technologies that address critical R&D issues to enable the development of better biopharmaceutical products. The Group's high margin service business has an established customer base that covers the majority of the major international biopharmaceutical companies. The Group also offers a range of value-added and complementary proprietary tec...

Person(s) interested:
Prior to Admission Shareholder Percentage of Existing Shares Imperial Innovations* 26.18% Invesco Asset Management Limited * 21.28% Proven Growth and Income VCT plc 5.27% The Advantage Enterprise & Innovation Fund 4.89% University College London 3.98% Dr Matthew Baker 3.88% Dr Francis (Frank) Carr 3.72% The Wellcome Trust Limited 3.64% The Capital Fund No 1 LP 3.07% *Invesco Asset Management Limited Invesco holds more than 20 per cent. of the voting rights attached to the issued share capital of Imperial Innovations. There is a presumption (which has not been rebutted) that Invesco Asset Management Limited and Imperial Innovations are acting in concert in relation to their shareholdings in Abzena. Post Admission Shareholder Percentage of Issued Share Capital Imperial Innovations* 23.56% Invesco Asset Management Limited * 26.58% Woodford Investment Management LLP 10.26% Proven Growth and Income VCT plc 3.95% The Advantage Enterprise & Innovation Fund 3.41% *Invesco Asset Management Limited Invesco holds more than 20 per cent. of the voting rights attached to the issued share capital of Imperial Innovations. There is a presumption (which has not been rebutted) that Invesco Asset Management Limited and Imperial Innovations are acting in concert in relation to their shareholdings in Abzena.


Abzena plc

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds